164 related articles for article (PubMed ID: 32545508)
1. Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
Pedone Anchora L; Carbone V; Gallotta V; Fanfani F; Cosentino F; Turco LC; Fedele C; Bizzarri N; Scambia G; Ferrandina G
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545508
[TBL] [Abstract][Full Text] [Related]
2. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
[TBL] [Abstract][Full Text] [Related]
3. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.
Liu X; Wang W; Hu K; Zhang F; Hou X; Yan J; Meng Q; Zhou Z; Miao Z; Guan H; Ma J; Shen J; Zhen H; Wang W
Sci Rep; 2020 Jan; 10(1):362. PubMed ID: 31941966
[TBL] [Abstract][Full Text] [Related]
4. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
[TBL] [Abstract][Full Text] [Related]
6. Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis.
Meng Q; Liu X; Hu K; Hou X; Zhang F; Wang W; Yan J; Yang B; Li W
J Cancer; 2023; 14(6):1001-1010. PubMed ID: 37151392
[No Abstract] [Full Text] [Related]
7. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
8. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
de Gregorio A; Widschwendter P; Ebner F; Friedl TWP; Huober J; Janni W; de Gregorio N
Oncology; 2020; 98(2):91-97. PubMed ID: 31593942
[TBL] [Abstract][Full Text] [Related]
9. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
[No Abstract] [Full Text] [Related]
11. Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer.
Chang H; Wang M; Liu Y; Wu Y
J Gynecol Oncol; 2023 Jul; 34(4):e46. PubMed ID: 36929577
[TBL] [Abstract][Full Text] [Related]
12. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China.
Liu X; Wang J; Hu K; Zhang F; Meng Q; Wang W; Wang D; Zhou Z; Ren K
Cancer Manag Res; 2020; 12():1405-1410. PubMed ID: 32161492
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
Duraker N; Caynak ZC
Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]